HomeMy WebLinkAboutMINUTES - 10282008 - C.78 TO: BOARD OF SUPERVISORS Contra
FROM.: William Walker,M.D., Health Services Director.
By: Jacqueline Pigg, Contracts Administrator "`` Costa
DATE: October 16, 2008 °� - County
r�Con'N`�;
SUBJECT: Polymedco Oc-Auto Micro 80 Analyzer and Reagent Commitment
SPECIFIC REQUEST(S)OR RECOMMENDATION(S)&BACKGROUND JUSTIFICATION
RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent on behalf of the Health Services Department
to execute a Purchase Order in the amount not to exceed $78,871.60 per year for the purchase of
required reagents and supplies to perform immunochemical Fecal Occult Blood Testing.
FISCAL IMPACT:
The cost of supplies is anticipated to be a minimum of $78,871.60 per year for a total of
$394,357.92 over the 5-year period based on the current number of tests performed.
The increased sensitivity and specificity of this test, over the current method, is expected to
improve detection of early stage colon cancer, the third most common cancer and the second
leading cause of cancer deaths in the United States, by as much as 30%. The increased specificity
resulting in few false positives, allows the correct identification of those patients who need
expensive Colonoscopy procedures. The US Preventive Services Task Force recommends that
adults age 50 to 75 be screened for colorectal cancer by one of the following three methods with
equal sensitivity: annual high-sensitivity fecal occult blood testing, sigmoidoscopy every five
years with fecal occult testing between sigmoidoscopic exams, or colonoscopy every 10 years.
Replacing the sigmoidoscopy and colonoscopy with this lab test for cancer screening will
significantly reduce the overall health care costs of the organization.
BACKGROUND/REASONS FOR RECOMMENDATIONS:
Polymedco's OC-Auto Micro 80 Analyzer with FOBT-CHEKoc Reagents is an automated
immunochemical fecal occult blood testing system that detects human red cells only with no
interferences from red meat, turnips, melons, aspirin, anti-inflammatory drugs and Vitamin C.
This improvement directs many more of the "right" patients to colonoscopy leading to the earlier
detection of polyps and colorectal cancer.
CONTINUED ON ATTACHMENT: X YES SIGNATURE:
RECOMMENDATION OF COUNTY ADMINISTRATOR RECOMMENDATION OF/BOARD COMMITTEE
APPROVE OTHER
SIGNATURE(S): ^- 1 �Q
ACTION OF BOARD ON stir d-L) . Y7� APPROVED AS RECOMMENDED /X OTHER
VOTE OF SUPERVISORS I HEREBY CERTIFY THAT THIS IS A TRUE
AND CORRECT COPY OF AN ACTION TAKEN
UNANIMOUS (ABSENT) AND ENTERED ON THE MINUTES OF THE BOARD
AYES: NOES: OF SUPERVISORS ON THE DATE SHOWN.
ABSENT: ABSTAIN:
Contact Person: Jeff Smith, M.D. 370-5113 ATTESTEDcc x( t
DAVILTTWA, CLERK OF THE BOARD OF
CC: Health Services Department (Contracts) SUPERVISORS AND COUNTY ADMINISTRATOR
Purchasing
BY DEPUTY
Board Order
Page 2
Polymedco Oc-Auto Micro 80 Analyzer and Reagent Commitment
Other advantages include: 1) The collection kid is simpler to use than the guaic card. 2) This
methodology requires only one sample compared to 3 samples of guaic, resulting in a higher
patient compliance rate. 3) There are no dietary restrictions as this is specific for human
hemoglobin.
The U.S. Preventive Services Task Force recommends that adults age 50 to 75 be screened for
colorectal cancer using annual high-sensitivity fecal occult blood testing, sigmoidoscopy every 5
years with fecal occult testing between sigmoidoscopic exams, or colonoscopy every 10 years.
Recently, the American Cancer Society and Multisociety Task Force on Colorectal Cancer also
endorsed Fecal Occult Blood Testing by immunohistochemical methods for colon cancer
screening. The CCRMC gastrointestinal specialists, internal medicine physicians as well as
Utilization Review and PCPC Committees strongly endorse this test. Fecal Occult Blood Testing
has become the community standard as both the Kaiser and John Muir systems have converted to
Polymedco's OC-Auto Micro 80 testing.